亲环素A(CYPA)检测试剂盒(酶联免疫吸附试验法)
ELISA Kit for Cyclophilin A (CYPA)
PPIA; CyP-A; CYPH; Peptidylprolyl Isomerase A; Peptidyl-Prolyl Isomerase A; Peptidyl-prolyl cis-trans isomerase A; Cyclosporin A-binding protein
- 编号SEA979Hu
- 物种Homo sapiens (Human,人) 相同的名称,不同的物种。
- 实验方法双抗夹心
- 反应时长3h
- 检测范围1.25-80ng/mL
- 灵敏度最小可检测剂量小于等于0.49ng/mL.
- 样本类型Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- 下载 英文说明书 中文说明书
- 规格 48T96T 96T*5 96T*10 96T*100
- 价格 ¥ 2646 ¥ 3780 ¥ 17010 ¥ 32130 ¥ 264600
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
特异性
本试剂盒用于检测亲环素A(CYPA),经检测与其它相似物质无明显交叉反应。
由于受到技术及样本来源的限制,不可能完成对所有相关或相似物质交叉反应检测,因此本试剂盒有可能与未经检测的其它物质有交叉反应。
回收率
分别于定值血清及血浆样本中加入一定量的亲环素A(CYPA)(加标样品),重复测定并计算其均值,回收率为测定值与理论值的比率。
样本 | 回收率范围(%) | 平均回收率(%) |
serum(n=5) | 85-99 | 89 |
EDTA plasma(n=5) | 96-105 | 101 |
heparin plasma(n=5) | 80-101 | 95 |
精密度
精密度用样品测定值的变异系数CV表示。CV(%) = SD/mean×100
批内差:取同批次试剂盒对低、中、高值定值样本进行定量检测,每份样本连续测定20 次,分别计算不同浓度样本的平均值及SD值。
批间差:选取3个不同批次的试剂盒分别对低、中、高值定值样本进行定量测定,每个样本使用同一试剂盒重复测定8次,分别计算不同浓度样本的平均值及SD值。
批内差: CV<10%
批间差: CV<12%
线性
在定值血清及血浆样本内加入适量的亲环素A(CYPA),并倍比稀释成1:2,1:4,1:8,1:16的待测样本,线性范围即为稀释后样本中亲环素A(CYPA)含量的测定值与理论值的比率。
样本 | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 83-98% | 95-104% | 90-104% | 86-102% |
EDTA plasma(n=5) | 96-103% | 87-95% | 91-98% | 86-98% |
heparin plasma(n=5) | 95-104% | 88-102% | 81-102% | 91-98% |
稳定性
经测定,试剂盒在有效期内按推荐温度保存,其活性降低率小于5%。
为减小外部因素对试剂盒破坏前后检测值的影响,实验室的环境条件需尽量保持一致,尤其是实验室内温度、湿度及温育条件。其次由同一实验员来进行操作可减少人为误差。
实验流程
1. 实验前标准品、试剂及样本的准备;
2. 加样(标准品及样本)100µL,37°C孵育1小时;
3. 吸弃,加检测溶液A100µL,37°C孵育1小时;
4. 洗板3次;
5. 加检测溶液B100µL,37°C孵育30分钟;
6. 洗板5次;
7. 加TMB底物90µL,37°C孵育10-20分钟;
8. 加终止液50µL,立即450nm读数。
实验原理
将亲环素A(CYPA)抗体包被于96孔微孔板中,制成固相载体,向微孔中分别加入标准品或标本,其中的亲环素A(CYPA)与连接于固相载体上的抗体结合,然后加入生物素化的亲环素A(CYPA)抗体,将未结合的生物素化抗体洗净后,加入HRP标记的亲和素,再次彻底洗涤后加入TMB底物显色。TMB在过氧化物酶的催化下转化成蓝色,并在酸的作用下转化成最终的黄色。颜色的深浅和样品中的亲环素A(CYPA)呈正相关。用酶标仪在450nm波长下测定吸光度(O.D.值),计算样品浓度。
增值服务
相关产品
编号 | 适用物种:Homo sapiens (Human,人) | 应用(仅供研究使用,不用于临床诊断!) |
RPA979Hu01 | 亲环素A(CYPA)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
CPA979Hu21 | 亲环素A(CYPA)卵白蛋白偶联物 | Immunogen; SDS-PAGE; WB. |
PAA979Hu08 | 亲环素A(CYPA)多克隆抗体 | WB; IHC; ICC; IP. |
PAA979Hu01 | 亲环素A(CYPA)多克隆抗体 | WB; IHC; ICC; IP; FCM |
LAA979Hu81 | 亲环素A(CYPA)多克隆抗体(异硫氰酸荧光素标记) | WB; IHC; ICC; IF. |
LAA979Hu71 | 亲环素A(CYPA)多克隆抗体(生物素标记) | WB; IHC; ICC. |
MAA979Hu22 | 亲环素A(CYPA)单克隆抗体 | WB,IHC,ICC/IF |
MAA979Hu23 | 亲环素A(CYPA)单克隆抗体 | WB; IHC; ICC; IP. |
MAA979Hu24 | 亲环素A(CYPA)单克隆抗体 | WB; IHC; ICC; IP. |
MAA979Hu25 | 亲环素A(CYPA)单克隆抗体 | WB; IHC; ICC; IP. |
MAA979Hu21 | 亲环素A(CYPA)单克隆抗体 | WB; IHC |
FAA979Hu02 | 抗亲环素A(CYPA)单克隆抗体 | Flow cytometry. |
FAA979Hu06 | 抗亲环素A(CYPA)单克隆抗体 | Flow cytometry. |
FAA979Hu08 | 抗亲环素A(CYPA)单克隆抗体 | Flow cytometry. |
LAA979Hu72 | 亲环素A(CYPA)单克隆抗体(生物素标记) | WB; IHC; ICC. |
SEA979Hu | 亲环素A(CYPA)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA979Hu | 亲环素A(CYPA)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
PSA979Hu01 | 亲环素A(CYPA)抗体对 | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
KSA979Hu01 | 亲环素A(CYPA)检测试剂盒DIY材料(酶联免疫吸附试验法) | Main materials for "Do It (ELISA Kit) Yourself". |
参考文献
杂志 | 参考文献 |
Atherosclerosis | EMMPRIN and its ligand cyclophilin A regulate MT1-MMP, MMP-9 and M-CSF during foam cell formation [PubMed: 19758589] |
Biomarkers | Cyclophilin-A: a novel biomarker for untreated male essential hypertension [Pubmed: 24164594] |
Cardiovascular Diabetology | Plasma level of cyclophilin A is increased in patients with type 2 diabetes mellitus and suggests presence of vascular disease [Pubmed:24502618] |
International Journal of Biological Sciences | Decrease in Plasma Cyclophilin A Concentration at 1 Month after Myocardial Infarction Predicts Better Left Ventricular Performance and Synchronicity at 6 Months: A Pilot Study in Patients with ST Elevation Myocardial Infarction [Pubmed:25552928] |
Medicine | Cyclophilin A in Ruptured Intracranial Aneurysm [PubMed: 26426668] |
Mol Cell Biochem | PPIA rs6850: A> G single-nucleotide polymorphism is associated with raised plasma cyclophilin A levels in patients with coronary artery disease [PubMed: 26702934] |
Medicine (Baltimore) | Urinary Cyclophilin A as a New Marker for Diabetic Nephropathy: A Cross-Sectional Analysis of Diabetes Mellitus [PubMed: 26496315] |
International Journal of Cardiology | Cyclophilin A modulates bone marrow-derived CD117(+) cells and enhances ischemia-induced angiogenesisvia the SDF-1/CXCR4 axis. [Pubmed:27057951] |
Clinica Chimica Acta | Novel findings of secreted cyclophilin A in diabetic nephropathy and its association with renal protection of dipeptidyl peptidase 4 inhibitor [pubmed:27823952] |
Cardiovascular Diabetology | Cyclophilin A enhances macrophage differentiation and lipid uptake in high glucose conditions: a cellular mechanism for accelerated macro vascular disease in diabetes mellitus. [pubmed:27809851] |
Clinical Science | Metformin attenuates effects of cyclophilin A on macrophages, reduces lipid uptake and secretion of cytokines by repressing decreased AMPK activity [Pubmed:29382697] |
Journal of Molecular Histology | Cyclophilin a increases CD68 cell infiltration in rat experimental periodontitis [Pubmed:29318411] |
Free Radical Research | Cyclophilin A and CD147 associate with progression of diabetic nephropathy [Pubmed: 30572748] |
The Kaohsiung Journal of Medical Sciences | Association of cyclophilin A level and pulse pressure in predicting recurrence of cerebral infarction [Pubmed: 31670477] |
Cells. | Cyclophilin A/EMMPRIN Axis Is Involved in Pro-Fibrotic Processes Associated with Thoracic Aortic Aneurysm of Marfan Syndrome Patients [Pubmed: 31936351] |
JAMA Neurology | APPENDIX A: Relationship between cyclophilin A levels and matrix metalloproteinase-9 activity in cerebrospinal fluid of cognitively normal apolipoprotein E4 carriers … [Pubmed: 24030206] |
Menoufia Medical Journal | Urinary podocalyxin and cyclophilin A: markers for early detection of type 2 diabetic nephropathy [] |
Toxins | Evaluation of the Therapeutic Effects of Protocatechuic Aldehyde in Diabetic Nephropathy [34437430] |
Cell Death & Disease | Proteomic analysis reveals USP7 as a novel regulator of palmitic acid-induced hepatocellular carcinoma cell death [Pubmed:35732625] |